Corbus Pharmaceuticals I... (CRBP)
NASDAQ: CRBP
· Real-Time Price · USD
9.25
-0.38 (-3.95%)
At close: Aug 15, 2025, 3:59 PM
9.43
1.95%
Pre-market: Aug 18, 2025, 04:00 AM EDT
Corbus Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 20.04M | 18.9M | 17.2M | 19.42M | 23.97M | 14.39M | 13.92M | 11.25M | 8.35M | 7.32M | 17M | 12.44M | 25.77M | 57.03M | 25.01M | 37.12M | 36.08M | 66.61M |
Short-Term Investments | n/a | 113.89M | 131.86M | 139.94M | 123.34M | 106M | 7.18M | 17.48M | 28.22M | 36.9M | 42.19M | 53.79M | 47.53M | 29.09M | 72.64M | 69.74M | 70.37M | 57.4M |
Long-Term Investments | n/a | n/a | n/a | n/a | 385K | 384.95K | 477.43K | 477.43K | 477.43K | n/a | 477.43K | 477.43K | 477.43K | 477.43K | 72.64M | 477.43K | 569.9K | 669.9K |
Other Long-Term Assets | 385K | 385K | 385K | 385K | n/a | n/a | 212.81K | 201.27K | 211.94K | 659.86K | 155.35K | 133.06K | 104.17K | 75.28K | -72.12M | n/a | 2.61K | 304.04K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M | 2.4M | 2.27M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 192.47K | 100K | 350K |
Other Current Assets | 102.78M | 4.57M | 3.91M | 285K | 124.63M | 1.31M | 192.47K | 192.47K | 192.47K | 1.64M | 192.47K | 192.47K | 192.47K | 192.47K | 192.47K | 192.47K | 100K | 350K |
Total Current Assets | 122.83M | 137.36M | 152.98M | 160.89M | 148.31M | 121.7M | 23.55M | 31.21M | 38.27M | 45.87M | 60.18M | 67.35M | 75.24M | 88.48M | 100.2M | 111.67M | 111.58M | 130.29M |
Property-Plant & Equipment | 1.88M | 2.19M | 2.52M | 2.9M | 3.28M | 3.66M | 4.04M | 4.4M | 4.76M | 5.12M | 5.5M | 5.87M | 6.25M | 6.65M | 7M | 7.43M | 8.46M | 8.88M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.26M | 2.57M | 2.9M | 3.28M | 3.67M | 4.05M | 4.73M | 5.08M | 5.45M | 5.78M | 6.13M | 6.48M | 6.83M | 7.2M | 7.53M | 7.91M | 9.03M | 9.86M |
Total Assets | 125.08M | 139.93M | 155.88M | 164.17M | 151.98M | 125.74M | 28.27M | 36.28M | 43.72M | 51.65M | 66.31M | 73.83M | 82.07M | 95.68M | 107.73M | 119.57M | 120.61M | 140.15M |
Account Payables | 3.99M | 4.07M | 4.79M | 2.89M | 1.15M | 2.08M | 3.18M | 4.71M | 1.51M | 1.32M | 2.17M | 1.37M | 1.99M | 2.7M | 1.78M | 2.55M | 1.88M | 3.62M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.55M | 6.42M | n/a | n/a | n/a | n/a | n/a | 10.09M | 13.37M | 15.09M | 17.74M |
Short-Term Debt | 1.7M | n/a | n/a | n/a | 10.82M | 12.95M | 16.21M | 19.25M | 8.42M | 5.21M | 3.15M | 9.88M | 7.59M | 5.62M | 3.86M | n/a | 102.69K | 408.28K |
Other Current Liabilities | 7.65M | 999K | 2.28M | 7.18M | n/a | 10.88K | 39.45K | 310.26K | 250K | 863.57K | 36.87K | 133.71K | 133.71K | 133.71K | 7.51M | 10.16M | 13.02M | 14.8M |
Total Current Liabilities | 13.33M | 11.62M | 11.82M | 11.63M | 23.98M | 25.92M | 31.89M | 31.54M | 16.39M | 14.36M | 12.64M | 17.47M | 15.63M | 15.12M | 17.01M | 17.14M | 18.74M | 23.61M |
Long-Term Debt | 761K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.32M | 13.97M | 15.98M | 9.39M | 11.61M | 13.73M | 15.64M | 18.55M | 18.37M | 18.2M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 44.41K | 819.41K | 2.52M | 2.52M | 22.2K | 22.2K | 22.2K | 22.2K | 22.2K | n/a | n/a | n/a |
Total Long-Term Liabilities | 761K | 1.21M | 1.63M | 2.05M | 2.46M | 2.86M | 3.28M | 4.43M | 17.82M | 20.83M | 20.68M | 14.42M | 16.97M | 19.4M | 21.61M | 24.8M | 24.91M | 25.02M |
Total Liabilities | 14.09M | 12.82M | 13.45M | 13.67M | 26.44M | 28.78M | 35.18M | 35.97M | 34.2M | 35.19M | 33.32M | 31.88M | 32.6M | 34.52M | 38.62M | 41.95M | 43.65M | 48.63M |
Total Debt | 2.46M | 2.85M | 3.24M | 3.61M | 14.8M | 17.29M | 20.88M | 22.86M | 23.72M | 24.84M | 25.09M | 25.52M | 25.74M | 26.17M | 26.59M | 25.9M | 26.09M | 26.47M |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1.05K | 442.00 | 442.00 | 442.00 | 422.00 | 417.00 | 12.53K | 12.53K | 12.53K | 12.52K | 12.52K | 12.51K | 12.5K |
Retained Earnings | -511.53M | -493.87M | -476.89M | -467.36M | -453.58M | -443.58M | -436.68M | -428.66M | -418.61M | -409.83M | -392.08M | -381.2M | -372.42M | -359.17M | -349.73M | -339.47M | -337.3M | -320.16M |
Comprehensive Income | -39K | -23K | 35K | 207K | -388K | -328.5K | -1.56K | -8.04K | -23.79K | -68.47K | -126.09K | -206.87K | -119.32K | -169.69K | -62.45K | -8.97K | -5.45K | -28.77K |
Shareholders Equity | 110.99M | 127.11M | 142.43M | 150.5M | 125.54M | 96.97M | -6.9M | 311.02K | 9.52M | 16.46M | 32.99M | 41.95M | 49.47M | 61.16M | 69.11M | 77.63M | 76.96M | 91.52M |
Total Investments | n/a | 113.89M | 131.86M | 139.94M | 123.72M | 106.39M | 7.66M | 17.48M | 28.22M | 36.9M | 42.19M | 53.79M | 47.53M | 29.09M | 72.64M | 69.74M | 70.37M | 57.4M |